Advising the AIM Medical Trust
“LHD has given us confidence to attack a number of issues that are more fore-sighted: the cost of gene therapy, cell therapy, and direct contracting.” – Gary Malone, Director of Trust Operations
“LHD has given us confidence to attack a number of issues that are more fore-sighted: the cost of gene therapy, cell therapy, and direct contracting.” – Gary Malone, Director of Trust Operations